Search

Your search keyword '"Gelmon, Karen"' showing total 1,248 results

Search Constraints

Start Over You searched for: Author "Gelmon, Karen" Remove constraint Author: "Gelmon, Karen"
1,248 results on '"Gelmon, Karen"'

Search Results

201. Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer

207. Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)

208. PUB0201081895

209. Triple negative breast cancer – Understanding the clinical implications of heterogeneity

228. Phase III Study of N,N-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19

233. Adjuvant systemic therapy and survival after breast cancer

240. Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2.

242. Abstract PD4-02: Canadian cancer trials group trial IND.231: A phase 1 trial evaluating CX-5461, a novel first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies

243. Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)

244. Abstract P1-19-16: Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for hormone receptor-positive/human epidermal growth factor receptor 2–negative advanced breast cancer: An updated analysis

247. Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

248. Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis

249. Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer

250. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

Catalog

Books, media, physical & digital resources